Results 151 to 160 of about 27,985 (262)

Ensifentrine Plus a Long-Acting Muscarinic Antagonist in COPD: A Trifunctional Dual Bronchodilation Perspective. [PDF]

Drugs
Cazzola M, Page CP, Calzetta L, Martinez FJ, Rogliani P, Matera MG.   +5 more
europepmc   +1 more source

Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study. [PDF]

Clin Pharmacol Drug Dev, 2020
Borin MT, Barnes CN, Darpo B, Pendyala S, Xue H, Bourdet DL.   +5 more
europepmc   +1 more source

Activity of aclidinium bromide, a new long‐acting muscarinic antagonist: a phase I study [PDF]

, 2010
Vanessa Schelfhout, P. Ferrer, Josep M. Jansat, Francesc Peris, Esther García Gil, Romain Pauwels, Guy Joos   +6 more
openalex   +1 more source

Adiabatic-Bias Molecular Dynamics Simulations Reveal the Impact of Mutations on Muscarinic Antagonist Unbinding Kinetics. [PDF]

J Chem Inf Model
Coricello A, Chiaravalle AL, Musgaard M, Tehan BG, Elisi GM, Bottegoni G.   +5 more
europepmc   +1 more source

Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice [PDF]

, 2011
Megan C. Wright, Amy Kim, Young‐Jin Son   +2 more
openalex   +1 more source

Quantitative Analysis of Muscarinic Antagonist Atropine and Tiotropium in Microvolume Plasma Using Liquid Chromatography-Mass Spectrometry: Application for Pharmacokinetic Studies. [PDF]

J Anal Methods Chem
Trancart M, Penot M, Meesemaecker G, Boffy R, Hanak AS, Calas AG, Taudon N.   +6 more
europepmc   +1 more source

Corrigendum to "Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium". [PDF]

Biomed Res Int, 2019
Hamelmann E.
europepmc   +1 more source

Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers. [PDF]

Int J Chron Obstruct Pulmon Dis, 2020
Singer D, Bengtson LGS, Elliott C, Buikema AR, Franchino-Elder J.   +4 more
europepmc   +1 more source

Dose-Related Efficacy of GSK573719: A Long-Acting Muscarinic Receptor Antagonist (LAMA) With Sustained 24-Hour Activity in COPD [PDF]

, 2011
James F. Donohue, Antonio Anzueto, Jean Brooks, Rashmi Mehta, Chris Kalberg, Glenn Crater   +5 more
openalex   +1 more source

Polypharmacy in mice disrupts left ventricular function and structure and promotes proteome reorganisation in an age‐ and sex‐specific fashion

British Journal of Pharmacology, Volume 182, Issue 19, Page 4625-4646, October 2025.
Background and Purpose Most older people use polypharmacy (≥5 medications), particularly those with cardiovascular disease. The effects of polypharmacy on the cardiovascular system are not well described. We examined the effect of a chronic polypharmacy regimen on left ventricular (LV) function, structure and proteome in young and old mice of both ...
Trang Tran, Kevin Winardi, Scott P. Levick, Alexander Widiapradja, Gizem Gemikonakli, Susan E. Howlett, Matthew J. McKay, Mark P. Molloy, John Mach, Sarah N. Hilmer   +9 more
wiley   +1 more source